Search results

Order by most recent / most popular / relevance

Results: 1-10 of 60

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

It takes two to tangoUK High Court considers patent for anti-malarial combination product obvious

A.A. Thornton & Co.
-
United Kingdom
-
April 24 2013

The UK High Court has recently handed down a further decision relating to the validity of pharmaceutical combination patents. In the decision

U.K. jumps on “pay-to-delay” bandwagon

Fish & Richardson PC
-
United Kingdom, USA
-
April 24 2013

The U.K. Office of Fair Trading ("OFT") jumped on the "pay-to-delay" bandwagon last week when it issued a "Statement of Objections," indicating a

GSK loses UK patent for the anti-malarial drug Malarone

Dehns
-
United Kingdom
-
April 3 2013

The UK Patents Court has found that GSK's patent for the anti-malarial drug Malarone (EP(UK) No. 0670719) is invalid. Malaria is one of the most

GSK v Comptroller - reference to the CJEU - can an adjuvant be the subject of an SPC?

Herbert Smith Freehills LLP
-
United Kingdom
-
March 26 2013

The Patents Court of England & Wales has requested that the CJEU clarifies the meaning of "product" in the SPC Regulation (Regulation 4692009). In

English courts will take jurisdiction for infringement of foreign patents!

Gowling Lafleur Henderson LLP
-
United Kingdom
-
March 25 2013

In conjoined cases: Actavis Group hf v Eli Lilly & Company (USA)Medis ehf v Eli Lilly & Company (USA) 2012 EWHC 3316 (Pat), Mr. Justice Arnold has

Malaria combination patent invalidated for obviousness

McDermott Will & Emery
-
United Kingdom
-
March 13 2013

In Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & Glaxo Group Ltd 2013 EWHC 148 (Pat) the High Court has held that

But finishing was never part of the (paediatric investigation) plan

Carpmaels & Ransford
-
United Kingdom
-
January 16 2013

The High Court recently rejected Dr Reddy’s application to revoke the six-month paediatric extension of Warner-Lambert’s supplementary protection

Court rejects challenge to paediatric extension of SPC for Lipitor

Arnold & Porter LLP
-
United Kingdom
-
January 9 2013

The Patents Court of England and Wales recently rejected a challenge brought by Dr Reddy's Laboratories against the six-month paediatric extension of the

Court of Appeal upholds invalidity of Alzheimer’s drug patent

McDermott Will & Emery
-
United Kingdom
-
January 9 2013

In Novartis AG v Generics (UK) Ltd (trading as Mylan) 2012 EWCA Civ 1623, the Court of Appeal has upheld the decision of the High Court that a patent

next >

Search results

IP challenges for the personalised medicines industry - gene claims (part 1)

It takes two to tangoUK High Court considers patent for anti-malarial combination product obvious

U.K. jumps on “pay-to-delay” bandwagon

GSK loses UK patent for the anti-malarial drug Malarone

GSK v Comptroller - reference to the CJEU - can an adjuvant be the subject of an SPC?

English courts will take jurisdiction for infringement of foreign patents!

Malaria combination patent invalidated for obviousness

But finishing was never part of the (paediatric investigation) plan

Court rejects challenge to paediatric extension of SPC for Lipitor

Court of Appeal upholds invalidity of Alzheimer’s drug patent

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea